The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be used in combination with an aromatase inhibitor as an adjuvant treatment for adults with hormone receptor (HR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback